Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Ueshima

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Annals of Nuclear Medicine|November 10, 2009
Prognostic value of myocardial perfusion SPECT images in combination with the maximal heart rate at exercise testing in Japanese patients with suspected ischemic heart disease: a sub-analysis of J-ACCESSKenji Ueshima, Akira Yamashina, Satoru Usami, et al.
Journal of Hypertension|May 12, 2018
Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in JapanJinliang Liu, Shinji Yasuno, Koji Oba, et al.
Diabetes Care|February 27, 2010
Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trialShinji Yasuno, Kenji Ueshima, Koji Oba, et al.
Clinical and Experimental Nephrology|January 11, 2014
Do statins play a role in renoprotection?Masato Kasahara, Takahiko Nakagawa, Hideki Yokoi, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 9, 2011
Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trialHiroaki Matsuoka, Katsuyuki Ando, Kenji Ueshima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2010
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trialKazuwa Nakao, Masakazu Hirata, Koji Oba, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 15, 2009
[Abnormal bone marrow uptake of 99mTc-tetrofosmin in myelodysplastic syndrome with ineffective hematopoiesis: a case report]Toshiya Okajima, Hiroshi Eizawa, Kenji Ueshima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 26, 2010
Impact of left ventricular hypertrophy on the time-course of renal function in hypertensive patients – a subanalysis of the CASE-J trial –Kenji Ueshima, Shinji Yasuno, Koji Oba, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2008
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trialToshio Ogihara, Kazuwa Nakao, Tsuguya Fukui, et al.
International Journal of Medical Sciences|August 13, 2013
Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trialKatsuayuki Ando, Kenji Ueshima, Sachiko Tanaka, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Annals of Nuclear Medicine|November 10, 2009
Prognostic value of myocardial perfusion SPECT images in combination with the maximal heart rate at exercise testing in Japanese patients with suspected ischemic heart disease: a sub-analysis of J-ACCESSKenji Ueshima, Akira Yamashina, Satoru Usami, et al.
Journal of Hypertension|May 12, 2018
Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in JapanJinliang Liu, Shinji Yasuno, Koji Oba, et al.
Diabetes Care|February 27, 2010
Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trialShinji Yasuno, Kenji Ueshima, Koji Oba, et al.
Clinical and Experimental Nephrology|January 11, 2014
Do statins play a role in renoprotection?Masato Kasahara, Takahiko Nakagawa, Hideki Yokoi, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 9, 2011
Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trialHiroaki Matsuoka, Katsuyuki Ando, Kenji Ueshima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2010
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trialKazuwa Nakao, Masakazu Hirata, Koji Oba, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 15, 2009
[Abnormal bone marrow uptake of 99mTc-tetrofosmin in myelodysplastic syndrome with ineffective hematopoiesis: a case report]Toshiya Okajima, Hiroshi Eizawa, Kenji Ueshima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 26, 2010
Impact of left ventricular hypertrophy on the time-course of renal function in hypertensive patients – a subanalysis of the CASE-J trial –Kenji Ueshima, Shinji Yasuno, Koji Oba, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2008
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trialToshio Ogihara, Kazuwa Nakao, Tsuguya Fukui, et al.
International Journal of Medical Sciences|August 13, 2013
Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trialKatsuayuki Ando, Kenji Ueshima, Sachiko Tanaka, et al.
Pageof 11